Valenta Pharm supported the organization of scientific symposiums within the framework of the XXII International congress of Russian pediatricians, which was held in Moscow on February 21-23.
The events presented antimicrobial strategies in the treatment of acute and recurrent respiratory infections and methods of treating functional digestive disorders in children.
Oleg Kalyuzhin, MD, prof. Department of Clinical Immunology and Allergology, Sechenov University spoke about the approach in choosing antiviral therapy for influenza and other acute respiratory viral infections. The expert noted the high efficiency of pentanedioic imidazolylethanamide (Ingavirin®), which works at any stage of the infection process.
Elena Melekhina, MD, Associate professor, senior researcher at the Central Research Institute of Epidemiology noted the role of inosine pranobex (Normomed®) in the treatment of infections that cause protracted and often recurring SARS episodes in children. The expert presented the results of her own clinical studies1 confirming the high effectiveness of Normomed against the HHV-6 virus.
In her speech, Elena Radzig, MD, professor, head. the training part of the Pirogov Medical University spoke about the modern principles of the treatment of inflammatory pathology of the throat.
The specialist noted the importance of a wide spectrum of action and a high safety profile of Grammidin in the treatment of infectious and inflammatory diseases of the throat.
Experts also talked about new opportunities in the treatment of functional disorders of the gastrointestinal tract in children.
Galina Volynets, MD, Prof., Head of the Department of Gastroenterology, Chief Researcher of the Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Medical University, dedicated to functional disorders of the biliary tract. Violation of the outflow of bile or pancreatic secretion into the intestines (dysfunction of the gallbladder, sphincter of Oddi and others) is often accompanied by dyspepsia and severe pain.The expert believes that trimebutin (Trimedat®) is an effective therapeutic measure for stopping the pathogenesis of functional digestive disorders. Depending on the state of gastrointestinal motility, the medicine has an antispasmodic or prokinetic effect, and also removes pain.
Svetlana Erdes, MD, prof. Head of the Department of Propaedeutics of childhood diseases of Filatov Clinical Institute of the Sechenov University spoke about the relationship of functional disorders of the gastrointestinal tract with changes in the composition of the intestinal microbiome.
The expert spoke about the features of microbiota, the importance of reducing its diversity in stomach pains, various functional disorders of the intestine (IBS, constipation).The expert believes that pre- and probiotic products containing strains of bifidobacteria and lactobacilli (Florasan®-D) are able to correct dysbiotic disorders in children. The medicine shows high efficiency with monotherapy and with trimebutine.
Elena Kornienko, MD, professor, chief freelance pediatric gastroenterologist of St. Petersburg, outlined the problem of chronic constipation, especially in children of the first year of life, spoke about the importance of short-chain fatty acids in normalizing bowel function. As a medicine therapy, the expert identified osmotic laxatives, which have a high status of effectiveness and safety. The specialist believes that lactitol (Exportal®) acts through short-chain fatty acids (butyrate) and is able to heal the intestinal mucosa and stop the increase in permeability on its walls.
Congress is a key event in the field of Russian pediatrics. The event annually brings together more than 10 000 experts and scientists, university teachers and students, pediatric doctors and other specialists working with children, nurses and paramedics of institutions of different departmental affiliations from Russia, CIS countries and abroad. Participants discuss the most important problems of modern pediatrics and exchange clinical, scientific and teaching experience.
- 1A comparative analysis of therapeutic regimens in children with monthly respiratory infections and reactivation of infection caused by human herpesvirus type 6, Melekhina E., Muzyka A.,Lysenkova M., Gorelov A., Practical pediatrics/V13, No5, (74–82 p.).